Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others
| Status: | Completed |
|---|---|
| Conditions: | Cancer, Cancer, Thyroid Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/22/2017 |
| Start Date: | June 2011 |
| End Date: | June 2017 |
The purpose of this study is to understand more about why some patients choose to have
surgery to treat their papillary microcarcinoma (PMC) and others choose to have their
papillary microcarcinoma (PMC) regularly watched by their doctor to see if and when they may
need surgery (referred to as "active surveillance"). The investigators also hope learn more
about what patients and their family members worry about or feel they will gain from surgery
or active surveillance.
surgery to treat their papillary microcarcinoma (PMC) and others choose to have their
papillary microcarcinoma (PMC) regularly watched by their doctor to see if and when they may
need surgery (referred to as "active surveillance"). The investigators also hope learn more
about what patients and their family members worry about or feel they will gain from surgery
or active surveillance.
Inclusion Criteria:
Thyroid cancer patient eligibility will include:
- Thyroid cancer patients who have been diagnosed with papillary microcarcinoma (or
subcentimeter thyroid lesions with fine needle aspiration biopsy suspicious for
papillary or follicular thyroid cancer) within the prior 6-12 months as per EMR path
report and clinician assessment;
- Presented with the option of treating their papillary microcarcinomas with either
surgery or active surveillance as per treating physician;
- English-fluent;
- 18 years of age or older;
Patient-designated significant other eligibility will include:
- Nomination by patient as individual who assisted patient in decision-making regarding
how to treat thyroid papillary microcarcinoma;
- English-fluent;
- 18 years of age or older;
Exclusion Criteria:
Thyroid cancer patient exclusion criteria will include:
- Thyroid cancer patients with known loco-regional or distant metastases prior to
initial surgical intervention as per path report.
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
